Aflac Incorporated

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

Is Aflac (AFL) Pricing Reflect Its Strong Multi‑Year Run And Mixed Valuation Signals

AI-generated analysis

📈 Aflac shares closed at US$113.07, reflecting 82.1% gains over the past three years and 140.0% over the past five years.

🎯 The stock carries a low valuation score of 2 out of 6 based on Simply Wall St's proprietary methodology.

💰 The Excess Returns model estimates an intrinsic value of US$176.79, suggesting the current price is approximately 36.0% undervalued.

📊 Aflac trades at a Price-to-Earnings (P/E) ratio of 15.98x, which is higher than both the insurance industry average of 11.54x and peer average of 14.69x.

🧮 Simply Wall St's Fair Ratio calculates a target P/E of 11.56x, implying Aflac may be trading at a premium relative to its specific risk and growth profile.

📈 Analysts project a Book Value of $59.86 per share and a Stable EPS of $8.35 per share for long-term forecasting.

💡 The Excess Returns model uses a Cost of Equity set at $4.18 per share, derived from weighted future Return on Equity estimates by five analysts.

🌐 Investor narratives vary between a fair value high of US$130.0 (optimistic outlook) and low of US$100.0 (risk-focused outlook).

🇯🇵 Specific concerns include the company's reliance on Japan markets, investment returns, and U.S. sales risks mentioned in community discussions.

⚖️ The analysis highlights that valuation methods can be compared directly against current share prices to determine potential upside or downside.

⚠️ This article is general commentary based on historical data and does not constitute specific financial advice or a recommendation to buy/sell.

📉 Management's business model positions the insurer within a competitive market landscape facing ongoing interest from investors.

Bullish Signals
  • Aflac has delivered strong long-term shareholder returns, with 82.1% growth over three years and 140.0% over the past five years.
  • The Excess Returns model calculates an intrinsic value of $176.79 per share, suggesting the stock is currently undervalued by approximately 36.0% at a closing price of $113.07.
  • Aflac trades on a P/E ratio of 15.98x, which is higher than both the industry average of 11.54x and the peer average of 14.69x, indicating investor confidence in its earnings growth.
  • Analysts estimate a stable EPS of $8.35 per share with an Average Return on Equity of 13.95%, demonstrating effective use of shareholders' equity to generate earnings above cost.
  • Product innovation, digitalization, and distribution reach are cited as potential drivers supporting higher analyst fair values around US$130.0.
Risk Factors
  • Aflac's valuation score is poor at just 2 out of 6 on Simply Wall St's checks, signaling potential concerns about its current price relative to value.
  • The stock trades at a P/E ratio of 15.98x, which is significantly higher than the Insurance industry average of 11.54x and above the peer average of 14.69x.
  • Simply Wall St's proprietary Fair Ratio model estimates a valuation of 11.56x, suggesting Aflac may be overpriced compared to its own specific risk and growth characteristics.
  • Analyst views are mixed on fair value targets, with some estimating US$100.0 based on concerns like Japan reliance, investment returns volatility, and U.S. sales risks.
  • The article explicitly notes that analysts are focused on mixed valuation signals rather than strong buy signals, indicating market uncertainty.
Full Analysis
Aflac (AFL) shares closed at US$113.07 with significant long-term gains, including 82.1% over the past three years and 140.0% over five years, reflecting a strong multi-year run that continues to attract investor attention. The article examines whether this valuation aligns with underlying fundamentals, noting Aflac received a valuation score of 2 out of 6 on Simply Wall St's platform. This low score is accompanied by specific red flags in the breakdown that suggest caution despite the impressive historical performance metrics such as recent returns of 2.3% over the last week and 10.4% over the past year. The analysis utilizes an Excess Returns model which calculates intrinsic value based on shareholder equity generation rather than cash flows. Using a Book Value of $56.85 per share and a Stable EPS of $8.35, with an Average Return on Equity of 13.95% against a Cost of Equity of $4.18, the model produces an intrinsic value estimate of approximately US$176.79 per share. This implies that based on the Excess Returns approach, Aflac is about 36.0% undervalued relative to its recent market price. However, traditional valuation metrics present a different picture, with Aflac currently trading at a P/E ratio of 15.98x. This P/E figure places Aflac above the Insurance industry average of 11.54x and the peer group average of 14.69x, suggesting the market is willing to pay a premium for its earnings compared to competitors. Simply Wall St's proprietary Fair Ratio analysis estimates a fair P/E of 11.56x, indicating that Aflac trades above this model-derived anchor when adjusted for specific factors like earnings growth and risk characteristics. The article concludes by suggesting investors can construct their own valuation narratives on the platform, linking financial forecasts to fair value estimates ranging from US$100.00 to US$130.00 to form a personal investment thesis that aligns with individual views on risks such as reliance on the Japan market and U.S. sales performance.